AC Immune ACIU
NASDAQ ACIU
$2.72 -0.09 (-3.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

AC Immune (ACIU) Other Accumulated Expenses (2015 - 2020)

Updated

AC Immune (ACIU) posted Other Accumulated Expenses of $130,265 for the quarter ended Mar 31, 2020.

Analysis

AC Immune (ACIU) Other Accumulated Expenses (2015 - 2020) Analysis & Trends

As of Dec 31, 2018, AC Immune's Other Accumulated Expenses came in at $1.16 million, up 149.5% from the prior year.

  • Annual Other Accumulated Expenses shows a three-year compound annual growth rate of -12.8% (years ended Dec 2015 to Dec 2018).
  • In prior years, AC Immune's Other Accumulated Expenses was $465,308 in the year ended Dec 31, 2017 (-43.9%), $829,681 in the year ended Dec 31, 2016 (-52.6%) and $1.75 million in the year ended Dec 31, 2015.
  • The figure for the quarter ended Mar 31, 2020 stands as the highest quarterly Other Accumulated Expenses since the quarter ended Dec 31, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 AC Immune 276.74 Mn 276.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 130,264.67
Dec 31, 2018 1.14 Mn
Dec 31, 2017 464,219.30
Dec 31, 2016 817,019.97
Dec 31, 2015 1.70 Mn
API Access

AC Immune Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACIU&period=max&api_key=YOUR_API_KEY